The gut microbiota has been linked to cardiovascular diseases. However, the composition
and functional capacity of the gut microbiome in relation to cardiovascular diseases have not …

Human gut microbiome is a promising target for managing type 2 diabetes (T2D). Measures
altering gut microbiota like oral intake of probiotics or berberine (BBR), a bacteriostatic agent…

Antidiabetic medication may modulate the gut microbiota and thereby alter plasma and
faecal bile acid (BA) composition, which may improve metabolic health. Here we show that …

Background COVID-19 (coronavirus disease 2019) has caused a major epidemic worldwide;
however, much is yet to be known about the epidemiology and evolution of the virus partly …

Background The gut microbiota evolves from birth and is in early life influenced by events
such as birth mode, type of infant feeding, and maternal and infant antibiotics use. However, …

Background More extensive use of metagenomic shotgun sequencing in microbiome research
relies on the development of high-throughput, cost-effective sequencing. Here we present …

Lifelong sex- and age-related trajectories of the human gut microbiota remain largely unexplored.
Using metagenomics, we derived the gut microbial composition of 2,338 adults (26–76 …

Background The gut microbiota plays important roles in modulating host metabolism.
Previous studies have demonstrated differences in the gut microbiome of T2D and prediabetic …

Non-fasting lipidemia (nFL), mainly contributed by postprandial lipidemia (PL), has recently
been recognized as an important cardiovascular disease (CVD) risk as fasting lipidemia (FL)…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global
pandemic of Coronavirus disease 2019 (COVID-19). However, the microbial composition of the …